Published Sep. 12, 2018 3:38 PM

Adipose derived stem cells (ASCs) are currently being investigated for a number of uses in regenerative medicine, but potential clinical use would require a robust method capable of producing a high number of cells.

In this article, Scholz Group member and PhD student Simen W. Schive et al. describe a method for large scale production of ASCs using automated systems, a workflow that could be used for future clinical trials. The manuscript was selected for the cover page in the current issue of CellR4.